Literature DB >> 22353418

Prolonged increase in rat hippocampal chemokine signalling after status epilepticus.

Anne A Kan1, W Saskia van der Hel, Sharon M Kolk, Ineke W M Bos, Suzanne A M W Verlinde, Onno van Nieuwenhuizen, Pierre N E de Graan.   

Abstract

Temporal lobe epilepsy (TLE) is one of the most common focal epilepsy syndromes. In a genome-wide expression study of the human TLE hippocampus we previously showed up-regulation of genes involved in chemokine signalling. Here we investigate in the rat pilocarpine model for TLE, whether changes in chemokine signalling occur during epileptogenesis and are persistent. Therefore we analysed hippocampal protein expression and cellular localisation of CCL2, CCL4, CCR1 and CCR5 after status epilepticus. We found increased CCL4 (but not CCL2) expression in specific populations of hilar astrocytes at 2 and 19 weeks after SE concomitant with a persistent up-regulation of its receptor CCR5. Our results show an early and persistent up-regulation of CCL4/CCR5 signalling during epileptogenesis and suggest that CCL4 signalling, rather than CCL2 signalling, could have a role in the epileptogenic process.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22353418     DOI: 10.1016/j.jneuroim.2012.01.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

1.  The histone lysine demethylase Kdm6b is required for activity-dependent preconditioning of hippocampal neuronal survival.

Authors:  Ranjula Wijayatunge; Liang-Fu Chen; Young May Cha; Anthony S Zannas; Christopher L Frank; Anne E West
Journal:  Mol Cell Neurosci       Date:  2014-06-28       Impact factor: 4.314

2.  The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.

Authors:  Katarzyna Pawlik; Anna Piotrowska; Klaudia Kwiatkowski; Katarzyna Ciapała; Katarzyna Popiolek-Barczyk; Wioletta Makuch; Joanna Mika
Journal:  Immunology       Date:  2020-02-05       Impact factor: 7.397

Review 3.  Immunity and Inflammation in Epilepsy.

Authors:  Annamaria Vezzani; Bethan Lang; Eleonora Aronica
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-18       Impact factor: 6.915

4.  Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression.

Authors:  Lindsay T Michalovicz; Gregory W Konat
Journal:  Metab Brain Dis       Date:  2013-12-24       Impact factor: 3.584

5.  Increased CCL2, CCL3, CCL5, and IL-1β cytokine concentration in piriform cortex, hippocampus, and neocortex after pilocarpine-induced seizures.

Authors:  Gabriel M Arisi; Maira L Foresti; Khurshed Katki; Lee A Shapiro
Journal:  J Neuroinflammation       Date:  2015-07-02       Impact factor: 8.322

Review 6.  Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders.

Authors:  Michael J Stuart; Gaurav Singhal; Bernhard T Baune
Journal:  Front Cell Neurosci       Date:  2015-09-10       Impact factor: 5.505

7.  The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory.

Authors:  Elodie Marciniak; Emilie Faivre; Patrick Dutar; Claire Alves Pires; Dominique Demeyer; Raphaëlle Caillierez; Charlotte Laloux; Luc Buée; David Blum; Sandrine Humez
Journal:  Sci Rep       Date:  2015-10-29       Impact factor: 4.379

8.  Neuronal Release of Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 Receptor Is Neuroprotective.

Authors:  Jason C Lim; Wennan Lu; Jonathan M Beckel; Claire H Mitchell
Journal:  Front Cell Neurosci       Date:  2016-11-23       Impact factor: 5.505

9.  Antiepileptogenic and Neuroprotective Effects of Pergularia daemia on Pilocarpine Model of Epilepsy.

Authors:  Antoine K Kandeda; Germain S Taiwe; Fleur C O Moto; Gwladys T Ngoupaye; Gisele C N Nkantchoua; Jacqueline S K Njapdounke; Jean P O Omam; Simon Pale; Nadege Kouemou; Elisabeth Ngo Bum
Journal:  Front Pharmacol       Date:  2017-06-30       Impact factor: 5.810

10.  Comparative analysis of cytokine/chemokine regulatory networks in patients with hippocampal sclerosis (HS) and focal cortical dysplasia (FCD).

Authors:  Arpna Srivastava; Aparna Banerjee Dixit; Debasmita Paul; Manjari Tripathi; Chitra Sarkar; P Sarat Chandra; Jyotirmoy Banerjee
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.